S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.
Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Lerchenmüller C, Mather PJ, Eckhart AD, Katus HA, Carrel T, Koch WJ, Most P.
Brinks H, et al.
J Am Coll Cardiol. 2011 Aug 23;58(9):966-73. doi: 10.1016/j.jacc.2011.03.054.
J Am Coll Cardiol. 2011.
PMID: 21851887
Free PMC article.